- Patent Title: Method of treating multiple sclerosis employing a LSD1-inhibitor
-
Application No.: US15741871Application Date: 2017-06-09
-
Publication No.: US10780081B2Publication Date: 2020-09-22
- Inventor: Tamara Maes , Cristina Mascarò Crusat , David Rotllant Pozo
- Applicant: ORYZON GENOMICS, S.A.
- Applicant Address: ES Madrid
- Assignee: Oryzon Genomics, S.A.
- Current Assignee: Oryzon Genomics, S.A.
- Current Assignee Address: ES Madrid
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@758bcdc6
- International Application: PCT/EP2017/064206 WO 20170609
- International Announcement: WO2017/212061 WO 20171214
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61P25/28 ; A61K31/42
Abstract:
Provided herein are methods for treating multiple sclerosis using (−) 5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof.
Public/Granted literature
- US20190083469A1 METHOD OF TREATING MULTIPLE SCHLEROSIS EMPLOYING A LSD1-INHIBITOR Public/Granted day:2019-03-21
Information query
